Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics

被引:44
作者
Trautmann, M
Zick, R
Rukavina, T
Cross, AS
Marre, R
机构
[1] Univ Ulm, Dept Med Microbiol & Hyg, D-89075 Ulm, Germany
[2] Univ Rijeka, Dept Microbiol, Rijeka, Croatia
[3] Univ Maryland, Greenbaum Canc Ctr, Dept Med, Baltimore, MD USA
[4] Univ Maryland, Div Infect Dis, Baltimore, MD USA
关键词
D O I
10.1093/jac/41.2.163
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The influence of meropenem, a new carbapenem antibiotic, on cell morphology and in-vitro lipopolysaccharide (LPS) release from Escherichia coli was compared with that of imipenem, ceftazidime, tobramycin and ciprofloxacin. Free and cell-associated LPS was quantified by means of a capture ELISA method based on the recognition of E. coli LPS by monoclonal antibodies. Microscopically, meropenem was found to induce spheroplast formation similar to that seen with imipenem, while ceftazidime and ciprofloxacin induced filament formation. Free and cell-associated LPS levels were low in the presence of meropenem, imipenem, ciprofloxacin and tobramycin, but high in the presence of ceftazidime. Reduced endotoxin release appears to be a common property of carbapenem antibiotics. Morphological changes in bacteria in the presence of antibiotics do not predict their LPS-liberating effect since ciprofloxacin induced low levels of LPS despite causing filament formation.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 30 条
[1]   INHIBITION OF ENDOTOXIN REACTIVITY BY AMINOGLYCOSIDES [J].
ARTENSTEIN, AW ;
CROSS, AS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (05) :826-828
[2]   A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia [J].
Bhattacharjee, AK ;
Opal, SM ;
Taylor, R ;
Naso, R ;
Semenuk, M ;
Zollinger, WD ;
Moran, EE ;
Young, L ;
Hammack, C ;
Sadoff, JC ;
Cross, AS .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) :1157-1163
[3]   DIFFERENTIAL ANTIBIOTIC-INDUCED RELEASE OF ENDOTOXIN FROM GRAM-NEGATIVE BACTERIA [J].
BUCKLIN, SE ;
FUJIHARA, Y ;
LEESON, MC ;
MORRISON, DC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 :43-51
[4]   DIFFERENCES IN THERAPEUTIC EFFICACY AMONG CELL WALL-ACTIVE ANTIBIOTICS IN A MOUSE MODEL OF GRAM-NEGATIVE SEPSIS [J].
BUCKLIN, SE ;
MORRISON, DC .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1519-1527
[5]  
CATCHPOLE RC, 1993, ANTIMICROBIAL AGENTS, V36, P1928
[6]   THE IMPORTANCE OF THE K1 CAPSULE IN INVASIVE INFECTIONS CAUSED BY ESCHERICHIA-COLI [J].
CROSS, AS ;
GEMSKI, P ;
SADOFF, JC ;
ORSKOV, F ;
ORSKOV, I .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (02) :184-193
[7]   ENDOTOXINS ROLE IN GRAM-NEGATIVE BACTERIAL-INFECTION [J].
CROSS, AS ;
OPAL, SM .
CURRENT OPINION IN INFECTIOUS DISEASES, 1995, 8 (03) :156-163
[8]   EFFECTS OF DIFFERENT TYPES AND COMBINATIONS OF ANTIMICROBIAL AGENTS ON ENDOTOXIN RELEASE FROM GRAM-NEGATIVE BACTERIA - AN INVITRO AND INVIVO STUDY [J].
DOFFERHOFF, ASM ;
NIJLAND, JH ;
DEVRIESHOSPERS, HG ;
MULDER, POM ;
WEITS, J ;
BOM, VJJ .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1991, 23 (06) :745-754
[9]   CIPROFLOXACIN FOR TREATMENT OF SEVERE TYPHOID-FEVER IN CHILDREN [J].
DUTTA, P ;
RASAILY, R ;
SAHA, MR ;
MITRA, U ;
BHATTACHARYA, SK ;
BHATTACHARYA, MK ;
LAHIRI, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1197-1199
[10]  
EDELMAN R, 1986, REV INFECT DIS, V8, P329